RAFT - Pace &Ablate

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 600 participants.

Also called NCT06299514

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 600 participants (planned count) (from the registry)
Sponsor
Habib Khan (from the registry)
Registry
  • NCT NCT06299514
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Canada (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT06299514. Randomized; single masking; primary purpose treatment. Start 2024-04-25 (actual); primary completion 2028-12-31 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
RAFT - Pace &Ablate
Acronym
RAFT-P&A RCT
Condition
Heart Failure
Condition
Pacemaker
Condition
Arrhythmia Atrial
Intervention (Device)
Pace and Ablate
Intervention (Drug)
Medication
Lead sponsor
Habib Khan (class: other)

Record details

Record id
cardio:ct-nct06299514
Content hash
47a533d7832873fd18b57c70915e7ad45dca12e3edc5c0d6fbb0d2d417899647